Is intraarterial tPA within 3 hours the treatment of choice for selected stroke patients?: No.
Lindley
Richard I
RI
Discipline of Medicine, Westmead Hospital (C24), The University of Sydney, NSW, Australia. Richard_lindley@wmi.usyd.edu.au
D005343:Fibrinolytic Agents / Q000008:administration & dosage* / Q000627:therapeutic use*; D006801:Humans; D007269:Injections, Intra-Arterial; D007275:Injections, Intravenous; D011379:Prognosis; D020521:Stroke / Q000175:diagnosis / Q000188:drug therapy*; D015912:Thrombolytic Therapy / Q000379:methods*; D013997:Time Factors; D010959:Tissue Plasminogen Activator / Q000008:administration & dosage* / Q000627:therapeutic use*
D005343:Fibrinolytic Agents; D010959:Tissue Plasminogen Activator